Literature DB >> 11469991

Psychologic Therapies for Irritable Bowel Syndrome.

Philip Boyce1.   

Abstract

The treatment of patients with irritable bowel syndrome (IBS) is a difficult task, as the results from therapy with pharmacologic agents have been disappointing. Psychologic treatments, in particular cognitive behavior therapy, hypnotherapy, and dynamic psychotherapy have all shown to be effective in the treatment of patients with IBS. Underpinning all these treatments is a clear understanding of a biopsychosocial model of interaction between emotion and gut function in IBS. These psychologic therapies are intended to break the negative feedback loop between emotion and gut function in order to reduce symptoms. Attention to the psychologic issues underlying IBS helps reduce psychosocial factors that maintain the presence of symptoms and inappropriate health-care seeking behavior. There are a number of common elements in the psychologic approaches that can be used in routine clinical practice; these include a detailed assessment, psychoeducation, support, and reassurance.

Entities:  

Year:  2001        PMID: 11469991     DOI: 10.1007/s11938-001-0058-7

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  57 in total

Review 1.  Fundamentals of neurogastroenterology.

Authors:  J D Wood; D H Alpers; P L Andrews
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

Review 2.  Anxiety and the irritable bowel syndrome: psychiatric, medical, or both?

Authors:  R B Lydiard
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

Review 3.  The irritable bowel syndrome: review and a graduated multicomponent treatment approach.

Authors:  D A Drossman; W G Thompson
Journal:  Ann Intern Med       Date:  1992-06-15       Impact factor: 25.391

4.  Functional gastrointestinal disorders: psychological, social, and somatic features.

Authors:  E J Bennett; C Piesse; K Palmer; C A Badcock; C C Tennant; J E Kellow
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

5.  Hypnotherapy in the treatment of irritable bowel syndrome: methods and results in Amsterdam.

Authors:  M Vidakovic-Vukic
Journal:  Scand J Gastroenterol Suppl       Date:  1999

6.  Cognitive-behaviour therapy as a treatment for irritable bowel syndrome: a pilot study.

Authors:  P Boyce; J Gilchrist; N J Talley; D Rose
Journal:  Aust N Z J Psychiatry       Date:  2000-04       Impact factor: 5.744

7.  The role of anxiety and depression in the irritable bowel syndrome.

Authors:  E B Blanchard; L Scharff; S P Schwarz; J M Suls; D H Barlow
Journal:  Behav Res Ther       Date:  1990

Review 8.  Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials.

Authors:  J Jailwala; T F Imperiale; K Kroenke
Journal:  Ann Intern Med       Date:  2000-07-18       Impact factor: 25.391

9.  The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome.

Authors:  I Heymann-Mönnikes; R Arnold; I Florin; C Herda; S Melfsen; H Mönnikes
Journal:  Am J Gastroenterol       Date:  2000-04       Impact factor: 10.864

Review 10.  Sexual and physical abuse and gastrointestinal illness. Review and recommendations.

Authors:  D A Drossman; N J Talley; J Leserman; K W Olden; M A Barreiro
Journal:  Ann Intern Med       Date:  1995-11-15       Impact factor: 25.391

View more
  3 in total

1.  Diarrhea- and Constipation-predominant Irritable Bowel Syndrome.

Authors:  Richard Lea; Peter J. Whorwell
Journal:  Curr Treat Options Gastroenterol       Date:  2001-08

2.  Are child anxiety and somatization associated with pain in pain-related functional gastrointestinal disorders?

Authors:  Amy E Williams; Danita I Czyzewski; Mariella M Self; Robert J Shulman
Journal:  J Health Psychol       Date:  2013-10-22

3.  Irritable bowel syndrome treatment: cognitive behavioral therapy versus medical treatment.

Authors:  Majid Mahvi-Shirazi; Ali Fathi-Ashtiani; Sayed-Kazem Rasoolzade-Tabatabaei; Mohsen Amini
Journal:  Arch Med Sci       Date:  2012-02-29       Impact factor: 3.318

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.